PLUS THERAPEUTICS director files initial Form 3
PLUS THERAPEUTICS, INC. director Ronald Asbury Andrews filed an initial Form 3 reporting his beneficial ownership in the company.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
PLUS THERAPEUTICS, INC. director Ronald Asbury Andrews filed an initial Form 3 reporting his beneficial ownership in the company. The filing shows he directly holds 0 shares of Common Stock as of the reported date, establishing a baseline ownership position for future insider reports.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
ANDREWS RONALD ASBURY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Common Stock | -- | -- | -- |
Holdings:
Common Stock — 0 shares (Direct)
Key Figures
Shares following reported position: 0.0000 shares
Insider role: Director
Security title: Common Stock
3 metrics
Shares following reported position
0.0000 shares
Total Common Stock directly owned after reported position
Insider role
Director
Reporting person role at PLUS THERAPEUTICS, INC.
Security title
Common Stock
Class of securities reported in Form 3
Key Terms
Form 3, Common Stock, beneficial ownership, direct ownership
4 terms
Form 3 regulatory
"INSIDER FILING DATA (Form 3): initial statement of beneficial ownership"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Common Stock financial
"security_title: Common Stock reported for PLUS THERAPEUTICS, INC."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
beneficial ownership financial
"Form 3 serves as the initial statement of beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
direct ownership financial
"ownership_type: direct with 0.0000 total shares following transaction"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Ronald Asbury Andrews’ Form 3 for PSTV report?
The Form 3 for PLUS THERAPEUTICS, INC. (PSTV) reports director Ronald Asbury Andrews’ initial beneficial ownership. It shows he directly holds 0 shares of Common Stock, creating a baseline for any future insider trading disclosures.
Does Ronald Asbury Andrews own PLUS THERAPEUTICS (PSTV) common stock according to this Form 3?
According to this Form 3, director Ronald Asbury Andrews directly owns 0 shares of Common Stock. This reflects his reported beneficial ownership at the time of filing and will serve as the reference point for later Form 4 or Form 5 updates.
Is there any buy or sell transaction disclosed in this PSTV Form 3?
No buy or sell transaction is disclosed. The data classifies the entry as a holding with an unknown transaction code and shows 0 shares following the reported position, consistent with a baseline ownership statement rather than a trade.
What security is covered in Ronald Asbury Andrews’ Form 3 for PLUS THERAPEUTICS?
The Form 3 covers Common Stock of PLUS THERAPEUTICS, INC.. It shows a direct ownership type with 0.0000 total shares following the reported position, indicating no directly held common shares at that time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
